EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanomaterials‐mediated glycolysis rewriting to potentiate tumor immunotherapy

Zilin Ma, Songyan Li, Jie Yan, Xuechun Wang, Wen Zhao, Yunxuan Song, Dongdong Liu, Jianwei Jiao, Xiuying Duan, Guiqiang Zhang

BMEMat · 2026-06 · 4 (2)

DOI: 10.1002/bmm2.70048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMEMat, online erschienen am 14.11.2025. Verfasst von Zilin Ma und 9 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 197 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy has emerged as a transformative paradigm in tumor therapy, but its clinical potential remains limited by the immunosuppressive tumor microenvironment driven by dysregulated tumor metabolism. Aerobic glycolysis, a hallmark of abnormal tumor metabolism, not only fuels tumor proliferation but also reshapes the tumor microenvironment through lactate accumulation, hypoxia, and competitive glucose consumption. Recent advances in nanomedicine offer innovative strategies to reprogram tumor glycolysis for enhanced immunotherapy, achieved through precision targeting of pivotal nodes of glycolysis pathways, including glucose transport, enzymatic activity, and lactate consumption. This review systematically summarizes cutting‐edge advances in glycolysis‐rewiring nanomedicines, emphasizing their mechanisms in reversing immunosuppression and reinvigorating antitumor immune responses. Challenges in clinical translation and future directions for designing multifunctional metabolic‐immune modulators are also critically discussed.

Förderung

  • Natural Science Foundation of Shandong Province
  • National Natural Science Foundation of China

Zitieren

APA

Ma, Z., Li, S., Yan, J., Wang, X., Zhao, W., Song, Y., Liu, D., Jiao, J., Duan, X., & Zhang, G. (2026). Nanomaterials‐mediated glycolysis rewriting to potentiate tumor immunotherapy. BMEMat, 4(2). https://doi.org/10.1002/bmm2.70048

Vancouver

Ma Z, Li S, Yan J, Wang X, Zhao W, Song Y, et al. Nanomaterials‐mediated glycolysis rewriting to potentiate tumor immunotherapy. BMEMat. 2026;4(2). doi:10.1002/bmm2.70048

BibTeX
@article{Ma2026,
  author = {Ma, Zilin and Li, Songyan and Yan, Jie and Wang, Xuechun and Zhao, Wen and Song, Yunxuan and Liu, Dongdong and Jiao, Jianwei and Duan, Xiuying and Zhang, Guiqiang},
  title = {Nanomaterials‐mediated glycolysis rewriting to potentiate tumor immunotherapy},
  journal = {BMEMat},
  year = {2026},
  volume = {4},
  number = {2},
  doi = {10.1002/bmm2.70048}
}
Kostenlos starten →